INFLECTION POINT ACQUISITION CORP. IV
For the period ended Dec 31, 2025. Filed Mar 12, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 12, 2026
MRLN$0.95-4.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibit and Financial Statement Schedules
Item 15. Exhibits, Financial Statements, and Schedules
| (1) | Financial Statements: |
| Page | |
| Report of Independent Registered Public Accounting Firm | F-2 |
|---|---|
| Consolidated Balance Sheets | F-3 |
| Consolidated Statements of Operations | F-4 |
| Consolidated Statements of Changes in Shareholders’ Deficit | F-5 |
| Consolidated Statements of Cash Flows | F-6 |
| Notes to Consolidated Financial Statements | F-7 to F-24 |
| (2) | Consolidated Financial Statement Schedules: |
None.
| (3) | Exhibits |
The exhibits listed in the Exhibit Index below are filed or incorporated by reference as part of this Annual Report on Form 10-K.
| Exhibit No. | Description |
| 1.1 | Underwriting Agreement, dated October 31, 2024, by and between the Company and Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC, as representative of the several underwriters (incorporated by reference to Exhibit 1.1 to the Registrant’s Current Report on Form 8-K (File No. 001-42392), filed with the SEC on November 5, 2024). |
| 1.2 | Amendment to Underwriting Agreement, dated August 5, 2025, by and between the Company and Cohen & Company Capital Markets, a division of J.V.B Financial Group, LLC, as representative of the several underwriters (incorporated by reference to Exhibit 1.1 to the Registrant’s Quarterly Report on Form 10-Q (File No. 001-42392), filed with the SEC on August 8, 2025). |
| 2.1† | Business Combination Agreement, dated as of August 13, 2025, by and among the Company, IPDX Merger Sub, Inc. and Merlin Labs, Inc. (incorporated by reference to Exhibit 2.1 to the Registrant’s Current Report on Form 8-K (File No. 001-42392), filed with the SEC on August 14, 2025). |
| 3.1 | Amended and Restated Memorandum and Articles of Association (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No. 001-42392), filed with the SEC on October 21, 2025). |
| 3.2 | Amendment to the Amended and Restated Memorandum and Articles of Association (incorporated by reference to Exhibit 3.2 to the Registrant’s Current Report on Form 8-K (File No. 001-42392), filed with the SEC on October 21, 2025). |
| 4.1 | Specimen Unit Certificate (incorporated by reference to Exhibit 4.1 to the Registrant’s Amendment No. 2 to the Registration Statement on Form S-1 (File No. 333-280777), filed with the SEC on October 7, 2024). |
| 4.2 | Specimen Ordinary Share Certificate (incorporated by reference to Exhibit 4.2 to the Registrant’s Amendment No. 2 to the Registration Statement on Form S-1 (File No. 333-280777), filed with the SEC on October 7, 2024). |
| 4.3 | Specimen Rights Certificate (incorporated by reference to Exhibit 4.3 to the Registrant’s Amendment No. 2 to the Registration Statement on Form S-1 (File No. 333-280777), filed with the SEC on October 7, 2024). |
| 4.4 | Share Rights Agreement, dated October 31, 2024, by and between the Company and Continental Stock Transfer & Trust Company, as rights agent (incorporated by reference to Exhibit 4.1 to the Registrant’s Current Report on Form 8-K (File No. 001-42392), filed with the SEC on November 5, 2024). |
| 4.5 | Description of Registered Securities (incorporated by reference to Exhibit 4.5 to the Registrant’s Annual Report on Form 10-K (File No. 001-42392), filed with the SEC on March 10, 2025). |
| 10.1 | Investment Management Trust Agreement, dated October 31, 2024, by and between the Company and Continental Stock Transfer & Trust Company, as trustee (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No. 001-42392), filed with the SEC on November 5, 2024). |
| 10.2 | Registration Rights Agreement, dated October 31, 2024, by and among the Company and certain security holders (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K (File No. 001-42392), filed with the SEC on November 5, 2024). |
| 10.3 | Private Placement Units Purchase Agreement, dated October 31, 2024, by and between the Company and the Sponsor (incorporated by reference to Exhibit 10.3 to the Registrant’s Current Report on Form 8-K (File No. 001-42392), filed with the SEC on November 5, 2024). |
| 10.4 | Letter Agreement, dated October 31, 2024, by and among the Company, its officers, directors and the Sponsor (incorporated by reference to Exhibit 10.4 to the Registrant’s Current Report on Form 8-K (File No. 001-42392), filed with the SEC on November 5, 2024). |
| 10.5 | Form of Indemnity Agreement (incorporated by reference to Exhibit 10.5 to the Registrant’s Current Report on Form 8-K (File No. 001-42392), filed with the SEC on November 5, 2024). |
| 10.6 | Consulting Agreement, dated July 28, 2025, by and between the Company and MJP Advisory Group LLC (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No. 001-42392), filed with the SEC on July 31, 2025). |
| 10.7 | Sponsor Support Agreement, dated August 13, 2025, by and among Bleichroeder Sponsor 1 LLC, Inflection Point Fund I, LP, the Company and Merlin Labs, Inc. (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No. 001-42392), filed with the SEC on August 14, 2025). |
| 10.8† | Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.6 to the Registrant’s Current Report on Form 8-K (File No. 001-42392), filed with the SEC on August 14, 2025). |
| 10.9 | Form of Amendment No. 1 to the Securities Purchase Agreement (Closing PIPE Subscription Agreement) (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No. 001-42392), filed with the SEC on November 17, 2025). |
| 10.10† | Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K (File No. 001-42392), filed with the SEC on November 17, 2025). |
| 14.1 | Code of Ethics (incorporated by reference to Exhibit 14.1 to the Registrant’s Amendment No. 2 to the Registration Statement on Form S-1 (File No. 333-280777), filed with the SEC on October 7, 2024). |
| 19 | Insider Trading Policies and Procedures, adopted October 16, 2024 (incorporated by reference to Exhibit 19 to the Registrant’s Annual Report on Form 10-K (File No. 001-42392), filed with the SEC on March 10, 2025). |
| 21.1 | List of Subsidiaries (incorporated by reference to Exhibit 21.1 to the Registrant’s Registration Statement on Form S-4 (File No. 333-292719) , filed with the SEC on February 12, 2026). |
| 31.1* | Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 31.2* | Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 32.1** | Certification of the Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| 32.2** | Certification of the Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| 97 | Policy Related to Recovery of Erroneously Awarded Compensation, adopted October 16, 2024. (incorporated by reference to Exhibit 97 to the Registrant’s Annual Report on Form 10-K (File No. 001-42392), filed with the SEC on March 10, 2025) |
| 99.1 | Audit Committee Charter (incorporated by reference to Exhibit 99.1 to the Registrant’s Amendment No. 2 to the Registration Statement on Form S-1 (File No. 333-280777), filed with the SEC on October 7, 2024). |
| 99.2 | Compensation Committee Charter (incorporated by reference to Exhibit 99.2 to the Registrant’s Amendment No. 2 to the Registration Statement on Form S-1 (File No. 333-280777), filed with the SEC on October 7, 2024). |
| 101.INS* | Inline XBRL Instance Document. |
| 101.SCH* | Inline XBRL Taxonomy Extension Schema Document. |
| 101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| 101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase Document. |
| 101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| 104* | Cover Page Interactive Data File (Embedded as Inline XBRL document and contained in Exhibit 101). |
| * | Filed herewith. |
|---|---|
| ** | Furnished herewith. |
| † | Certain of the exhibits and schedules to this exhibit have been omitted in accordance with Regulation S-K Item 601(b)(2). The Registrant agrees to furnish supplementally a copy of all omitted exhibits and schedules to the SEC upon its request. |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.